Vallon Pharmaceuticals, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.00 | $0 | |||
05/10/2024 | Q1 2024 | -$0.00 | $0 | |||
03/28/2024 | Q4 2023 | -$0.00 | $0 | |||
11/14/2023 | Q3 2023 | -$0.00 | $0 | |||
08/14/2023 | Q2 2023 | -$0.24 | $0 | |||
05/15/2023 | Q1 2023 | -$0.02 | $0 | |||
02/23/2023 | Q4 2022 | -$0.22 | $0 | |||
11/03/2022 | Q3 2022 | -$0.25 | -$0.02 | 0.23 | $0 | |
07/28/2022 | Q2 2022 | -$0.23 | -$0.20 | 0.03 | $0 | |
05/09/2022 | Q1 2022 | -$0.22 | -$0.39 | -0.17 | $0 | |
02/14/2022 | Q4 2021 | -$0.22 | -$0.45 | -0.23 | $0 | |
11/12/2021 | Q3 2021 | -$0.18 | $0 | |||
08/10/2021 | Q2 2021 | -$0.34 | $0 | |||
05/13/2021 | Q1 2021 | -$0.46 | $0 | |||
03/29/2021 | Q4 2020 | -$0.26 | $0 | |||
09/29/2020 | Q3 2020 | -$0.15 | $0 | |||
06/29/2020 | Q2 2020 | -$0.17 | $0 | |||
03/30/2020 | Q1 2020 | -$0.17 | $100,000 | |||
12/30/2019 | Q4 2019 | -$0.13 | $0 | |||
09/29/2019 | Q3 2019 | -$0.14 | $0 |
Vallon Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Vallon Pharmaceuticals, Inc.'s earnings date?
Vallon Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 26th, 2023 based off last year's report dates.
-
How can I listen to Vallon Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Vallon Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Vallon Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Vallon Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Vallon Pharmaceuticals, Inc. generate each year?
Vallon Pharmaceuticals, Inc. (:VLON) has a recorded net income of $0. Vallon Pharmaceuticals, Inc. has generated $-1.29 earnings per share over the last four quarters.
-
What is Vallon Pharmaceuticals, Inc.'s price-to-earnings ratio?
Vallon Pharmaceuticals, Inc. (:VLON) has a price-to-earnings ratio of -22.13 and price/earnings-to-growth ratio is 0.27.